Schedule 13G ownership disclosure

CytomX Therapeutics Inc

Security class unavailable · CUSIP: 23284F105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,500,300
Percent of class
9.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-21-000089
Form type
SC 13G
Filer
CytomX Therapeutics, Inc.
CIK
CIK 1501989
Filed
Jan 26, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub